JP2016513090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016513090A5 JP2016513090A5 JP2015556243A JP2015556243A JP2016513090A5 JP 2016513090 A5 JP2016513090 A5 JP 2016513090A5 JP 2015556243 A JP2015556243 A JP 2015556243A JP 2015556243 A JP2015556243 A JP 2015556243A JP 2016513090 A5 JP2016513090 A5 JP 2016513090A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- nanoparticles
- nanoparticle
- core
- medically useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361761012P | 2013-02-05 | 2013-02-05 | |
| US61/761,012 | 2013-02-05 | ||
| PCT/US2014/014751 WO2014123935A1 (en) | 2013-02-05 | 2014-02-05 | Biodegradable and clinically-compatible nanop articles as drug delivery carriers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016513090A JP2016513090A (ja) | 2016-05-12 |
| JP2016513090A5 true JP2016513090A5 (enExample) | 2017-03-02 |
| JP6507102B2 JP6507102B2 (ja) | 2019-04-24 |
Family
ID=51300093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015556243A Active JP6507102B2 (ja) | 2013-02-05 | 2014-02-05 | 薬物送達キャリアとしての生分解性でかつ臨床上適合性のナノ粒子 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11001840B2 (enExample) |
| EP (2) | EP3845248A1 (enExample) |
| JP (1) | JP6507102B2 (enExample) |
| KR (1) | KR20150132131A (enExample) |
| AU (2) | AU2014215421A1 (enExample) |
| CA (1) | CA2899155A1 (enExample) |
| ES (1) | ES2873600T3 (enExample) |
| IL (1) | IL240148A0 (enExample) |
| MX (1) | MX2015010083A (enExample) |
| RU (1) | RU2015137815A (enExample) |
| SG (2) | SG11201506116XA (enExample) |
| WO (1) | WO2014123935A1 (enExample) |
| ZA (1) | ZA201506530B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2873600T3 (es) | 2013-02-05 | 2021-11-03 | 1Globe Health Inst Llc | Nanopartículas biodegradables y clínicamente compatibles como vehículos de suministro de fármacos. |
| CA2919268C (en) | 2013-07-25 | 2023-09-05 | Exicure, Inc. | Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use |
| AU2015269412B2 (en) | 2014-06-04 | 2020-03-12 | Exicure Operating Company | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications |
| EP3183007B1 (en) | 2014-08-19 | 2020-06-17 | Northwestern University | Protein/oligonucleotide core-shell nanoparticle therapeutics |
| WO2016081911A2 (en) | 2014-11-21 | 2016-05-26 | Northwestern University | The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
| EP3247796A4 (en) * | 2015-01-14 | 2018-07-11 | Exicure, Inc. | Nucleic acid nanostructures with core motifs |
| CA3023451A1 (en) | 2016-05-06 | 2017-11-09 | Exicure, Inc. | Liposomal spherical nucleic acid (sna) constructs presenting antisense oligonucleotides (aso) for specific knockdown of interleukin 17 receptor mrna |
| WO2018039629A2 (en) | 2016-08-25 | 2018-03-01 | Northwestern University | Micellar spherical nucleic acids from thermoresponsive, traceless templates |
| WO2018098352A2 (en) | 2016-11-22 | 2018-05-31 | Jun Oishi | Targeting kras induced immune checkpoint expression |
| US10800817B2 (en) * | 2016-12-19 | 2020-10-13 | Morehouse School Of Medicine | Compositions and methods for treating diseases by inhibiting exosome release |
| PL3568122T3 (pl) * | 2017-01-10 | 2024-03-18 | Dukebox Sp. Z O.O. | Sposób wytwarzania zawiesiny nanocząsteczek soli potasowej albo soli magnezowej |
| WO2018201090A1 (en) | 2017-04-28 | 2018-11-01 | Exicure, Inc. | Synthesis of spherical nucleic acids using lipophilic moieties |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| KR102120482B1 (ko) * | 2018-10-05 | 2020-06-08 | 씨제이제일제당 (주) | 생분해성 고분자 나노입자를 포함하는 메모리 소자 및 이의 제조방법 |
| EP3996751A1 (en) * | 2019-07-12 | 2022-05-18 | The Board Of Trustees Of The Leland Stanford Junior University | Functionalized nanoparticles and their use in treating bacterial infections |
| US20240050369A1 (en) * | 2019-10-04 | 2024-02-15 | The University Of Chicago | Targeted Nanomedicine for Treating Vascular Disorders |
| WO2021158476A1 (en) * | 2020-02-03 | 2021-08-12 | Rutgers, The State University Of New Jersey | Microrna-7 compositions for promoting functional recovery following spinal cord injury and methods of use thereof |
| US11998615B2 (en) | 2021-04-14 | 2024-06-04 | The Board Of Trustees Of The Leland Stanford Junior University | Functionalized nanoparticles and their use in treating bacterial infections |
| CN120714059A (zh) * | 2025-05-28 | 2025-09-30 | 首都医科大学附属北京安贞医院 | 一种多羟基核酸药物共递送系统及其制备方法和应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5219577A (en) | 1990-06-22 | 1993-06-15 | The Regents Of The University Of California | Biologically active composition having a nanocrystalline core |
| TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
| US5879715A (en) * | 1997-09-02 | 1999-03-09 | Ceramem Corporation | Process and system for production of inorganic nanoparticles |
| DE19856432A1 (de) * | 1998-12-08 | 2000-06-15 | Basf Ag | Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen |
| DE19912502A1 (de) | 1999-03-19 | 2000-09-21 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung |
| EP1328254B1 (en) | 2000-10-25 | 2007-02-21 | The University Of British Columbia | Lipid formulations for target delivery |
| IN192520B (enExample) * | 2001-08-01 | 2004-04-24 | Univ Delhi | |
| AU2004257373B2 (en) | 2003-07-16 | 2011-03-24 | Arbutus Biopharma Corporation | Lipid encapsulated interfering RNA |
| EP1720520B1 (en) | 2004-02-13 | 2010-06-09 | Nod Pharmaceuticals, Inc. | Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof |
| US7611690B2 (en) * | 2005-01-04 | 2009-11-03 | Gp Medical, Inc. | Nanoparticles for protein drug delivery |
| WO2007000939A1 (ja) | 2005-06-28 | 2007-01-04 | St. Marianna University, School Of Medicine | 局所炎症治療用薬剤 |
| CN100435784C (zh) | 2005-07-25 | 2008-11-26 | 管晓虹 | 含有和包封中药成分的无机盐纳米粒子的制备方法 |
| WO2008045806A2 (en) * | 2006-10-06 | 2008-04-17 | Microislet, Inc. | Multilayered polyelectrolyte-based capsules for cell encapsulation and delivery of therapeutic compositions |
| CN101686939B (zh) | 2007-04-17 | 2013-03-27 | 巴克斯特国际公司 | 用于肺部投送的核酸微粒 |
| EP2164475A2 (en) * | 2007-07-16 | 2010-03-24 | NorthEastern University | Therapeutic stable nanoparticles |
| EP3121281B1 (en) * | 2007-08-27 | 2021-03-31 | 1Globe Health Institute LLC | Compositions of asymmetric interfering rna and uses thereof |
| WO2009042625A1 (en) | 2007-09-25 | 2009-04-02 | Idexx Laboratories, Inc. | Pharmaceutical compositions for administering oligonucleotides |
| EP2241314B1 (en) | 2007-12-14 | 2013-04-17 | Ezaki Glico Co., Ltd. | Alpha-lipoic acid nanoparticle and method for producing the same |
| US20110038941A1 (en) | 2007-12-27 | 2011-02-17 | The Ohio State University Research Foundation | Lipid Nanoparticle Compositions and Methods of Making and Using the Same |
| WO2009140421A2 (en) | 2008-05-13 | 2009-11-19 | University Of Washington | Polymeric carrier |
| JP2012509904A (ja) | 2008-11-26 | 2012-04-26 | ユニバーシティ・オブ・カンザス | 核酸送達組成物および核酸送達法 |
| EP2198885B1 (en) | 2008-12-19 | 2012-02-08 | Biolitec AG | Calcium phosphate nanoparticles as dye carrier for photodynamic therapy |
| WO2011017297A2 (en) * | 2009-08-03 | 2011-02-10 | The University Of North Carolina At Chapel Hill | Biodegradable delivery system complexes for the delivery of bioactive compounds |
| JP2013504337A (ja) * | 2009-09-14 | 2013-02-07 | ナノハイブリッド カンパニー リミテッド | 標的特異的ｓｉＲＮＡ−層状無機水酸化物ナノハイブリッド、その製造方法、及びナノハイブリッドを含有する腫瘍治療用の医薬組成物 |
| JP5491119B2 (ja) * | 2009-10-02 | 2014-05-14 | 日東電工株式会社 | 薬物含有微粒子を含む医薬組成物およびその製造方法 |
| WO2011140024A2 (en) * | 2010-05-03 | 2011-11-10 | University Of Utah Research Foundation | Nanoparticles produced from recombinant polymers and methods of making and using the same |
| WO2013040295A2 (en) | 2011-09-14 | 2013-03-21 | University Of South Florida | Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation |
| CA2853689C (en) | 2011-11-04 | 2020-06-30 | Nitto Denko Corporation | Method of producing lipid nanoparticles for drug delivery |
| US20130243699A1 (en) | 2011-12-07 | 2013-09-19 | Regents Of The University Of Minnesota | Biodegradable Magnetic Nanoparticles and Related Methods |
| ITRM20120480A1 (it) | 2012-10-09 | 2014-04-10 | Uni Degli Studi Camerino | Nanoparticelle lipidiche multicomponenti e procedimenti per la loro preparazione. |
| ES2873600T3 (es) | 2013-02-05 | 2021-11-03 | 1Globe Health Inst Llc | Nanopartículas biodegradables y clínicamente compatibles como vehículos de suministro de fármacos. |
-
2014
- 2014-02-05 ES ES14748796T patent/ES2873600T3/es active Active
- 2014-02-05 JP JP2015556243A patent/JP6507102B2/ja active Active
- 2014-02-05 WO PCT/US2014/014751 patent/WO2014123935A1/en not_active Ceased
- 2014-02-05 RU RU2015137815A patent/RU2015137815A/ru not_active Application Discontinuation
- 2014-02-05 MX MX2015010083A patent/MX2015010083A/es unknown
- 2014-02-05 CA CA2899155A patent/CA2899155A1/en not_active Abandoned
- 2014-02-05 EP EP20204049.9A patent/EP3845248A1/en active Pending
- 2014-02-05 EP EP14748796.1A patent/EP2953646B1/en active Active
- 2014-02-05 SG SG11201506116XA patent/SG11201506116XA/en unknown
- 2014-02-05 US US14/765,763 patent/US11001840B2/en active Active
- 2014-02-05 AU AU2014215421A patent/AU2014215421A1/en not_active Abandoned
- 2014-02-05 KR KR1020157024176A patent/KR20150132131A/ko not_active Withdrawn
- 2014-02-05 SG SG10201706968UA patent/SG10201706968UA/en unknown
-
2015
- 2015-07-26 IL IL240148A patent/IL240148A0/en unknown
- 2015-09-04 ZA ZA2015/06530A patent/ZA201506530B/en unknown
-
2018
- 2018-02-07 AU AU2018200903A patent/AU2018200903A1/en not_active Abandoned
-
2021
- 2021-04-06 US US17/223,647 patent/US20210230595A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015137815A (ru) | Биодеградируемые и клинически совместимые наночастицы в качестве носителей для доставки лекарственного средства | |
| Lim et al. | Polymeric nanoparticles in development for treatment of pulmonary infectious diseases | |
| Zhao et al. | Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis | |
| CN106793970B (zh) | 用于诊断及治疗的纳米载剂及其加工 | |
| KR101243689B1 (ko) | 미립자 및 의약품 조성물 | |
| Bassyouni et al. | Advances and new technologies applied in controlled drug delivery system | |
| US11850309B2 (en) | Cationic materials and formulations for drug delivery | |
| Cheng et al. | Cell-mediated nanoparticle delivery systems: towards precision nanomedicine | |
| He et al. | Recent development of poly (ethylene glycol)-cholesterol conjugates as drug delivery systems | |
| CN103040724B (zh) | 含聚合物与磷脂的纳米载药系统及其制备方法 | |
| KR20140138639A (ko) | 점막 침투 강화를 나타내는 나노 입자 제형 | |
| Wang et al. | Advanced hitchhiking nanomaterials for biomedical applications | |
| US20220175953A1 (en) | Biomimetic anisotropic polymeric particles with naturally derived cell membranes for enhanced drug delivery | |
| Liu et al. | Use of nanoformulation to target macrophages for disease treatment | |
| AU2020205473B2 (en) | Polymersomes functionalised with multiple ligands | |
| KR20140084144A (ko) | 출혈 제어 및 약물 전달을 위한 나노입자 | |
| Naghib et al. | Stimuli-sensitive chitosan-based nanosystems-immobilized nucleic acids for gene therapy in breast cancer and hepatocellular carcinoma | |
| KR100792557B1 (ko) | 나노 캡슐화를 이용하여 제조된 지질 핵 및 고분자 쉘구조를 갖는 단백질 약물 전달용 나노 미립구 | |
| Shi et al. | Advances in nanotherapy for targeting senescent cells | |
| Chinnagounder Periyasamy et al. | Nanomaterials for the local and targeted delivery of osteoarthritis drugs | |
| Adnan et al. | Peptide-Based Nanocarriers for Targeted Drug Delivery: Recent Advances, Strategies, and Therapeutic Frontiers | |
| CN111107842A (zh) | 利用微混合和卡培他滨两亲性特性的卡培他滨的聚合物-脂质混杂纳米颗粒 | |
| CN107519496B (zh) | 一类l-肉毒碱两亲性衍生物及其修饰的纳米粒及其用途 | |
| Barbosa et al. | Nanotechnology applied in drug delivery | |
| Liu et al. | Aptamer-based drug delivery systems |